| Line Item | 2025-06-30 | Y/Y |
|---|---|---|
| Revenue | $696.2M | +5.9% |
| Cost of Revenue | $535.2M | +10.3% |
| Gross Profit | $161.0M | -6.3% |
| R&D Expense | $94.3M | +4.8% |
| SG&A Expense | $95.2M | +11.0% |
| Operating Income | -$28.4M | -657.1% |
| Pre-tax Income | -$27.8M | -951.7% |
| Income Tax | -$8.6M | -336.4% |
| Net Income | -$97.0M |
| Line Item | 2025-06-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $153.1M | -12.6% |
| Accounts Receivable | $34.8M | +177.2% |
| Inventory | $189.7M | -3.1% |
| Current Assets | $396.2M | -0.5% |
| Total Assets | $1.03B | -9.7% |
| Current Liabilities | $154.5M | +0.2% |
| Long-term Debt | $14.9M | -44.3% |
| Line Item | 2025-06-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | $29.7M | +15.4% |
| Capital Expenditures | $37.2M | +0.2% |
| Investing Cash Flow | -$36.4M | -1.9% |
| Financing Cash Flow | -$15.5M | -56.5% |
| Free Cash Flow | -$7.5M | +34.0% |
| -775.2% |
| EPS (Basic) | -$3.30 | -746.2% |
| EPS (Diluted) | -$3.30 | -746.2% |
| Total Liabilities |
| $212.0M |
| -16.4% |
| Stockholders' Equity | $822.3M | -7.8% |